ES2196312T3 - Derivados azaheterociclimetilo de 3,3,9 -tetrahidro-7h 1,4-dioxino (2,3-4) indol-8-0na. - Google Patents

Derivados azaheterociclimetilo de 3,3,9 -tetrahidro-7h 1,4-dioxino (2,3-4) indol-8-0na.

Info

Publication number
ES2196312T3
ES2196312T3 ES97910866T ES97910866T ES2196312T3 ES 2196312 T3 ES2196312 T3 ES 2196312T3 ES 97910866 T ES97910866 T ES 97910866T ES 97910866 T ES97910866 T ES 97910866T ES 2196312 T3 ES2196312 T3 ES 2196312T3
Authority
ES
Spain
Prior art keywords
optionally substituted
defined above
hydrogen
phenyl
benzoisothiazolyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97910866T
Other languages
English (en)
Inventor
Gary Paul Stack
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
Wyeth LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth LLC filed Critical Wyeth LLC
Application granted granted Critical
Publication of ES2196312T3 publication Critical patent/ES2196312T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

LA INVENCION SE REFIERE A LOS COMPUESTOS DE FORMULA (I), DONDE X ES H 2 O O; R 1 ES HIDROGENO, HIDROXILO, HALO, TRIFLUOROMETILO, TRIFLUOROMETOXI, ALQUILO, ALCOXI, ARALCOXI, ALCANOILOXI, AMINO, MONO- O DIALQUILAMINO, ALCANAMIDO O ALCANOSULFONAMIDO; Z SE DEFINE MEDIANTE LAS FORMULAS (II), (III) O (IV), DONDE R 2 ES HIDROGENO, ALQUILO, CICLOALQUILO, FENILO OPCIONALMENTE SUSTITUIDO POR R 1 , TAL Y COMO SE DEFINIO ANTERIORMENTE, OM - FENILALQUILO, O OM DIFENILALQUILO, EN EL CUAL EL ANILLO DE FENILO SE SUSTITUYE OPCIONALMENTE POR R SUP,1 , TAL Y COMO SE DEFINIO ANTERIORMENTE, O R 2 ES NAFT ILO, INDOLILO, INDAZOLILO, TIENILO, PIRIDINILO, PIRIMIDINILO, QUINOLINILO, BENZOISOTIAZOLILO O BENCISOXAZOLILO, CADA UNO OPCIONALMENTE SUSTITUIDO POR R 1 , TAL Y COMO SE DEFINIO ANTE RIORMENTE; O R 4 ES - Y - AR, EN DONDE Y ES C = O, CHOH O (CH 2 ) M , DONDE M ESTA COMPRENDIDO ENTRE 0 Y 4, Y AR ES FENILO, OPCIONALMENTE SUSTITUIDO POR R 1 , TAL Y COMO SE DEFINIO ANTERIORMENTE; O R 3 Y R 4 , TOMADOS CONJUNTAMENTECON EL ATOMO DE CARBONO AL CUAL ESTAN UNIDOS, FORMAN (V) O (VI), DONDE R 5 ES HIDROGENO Y R 6 ES FENILO, NAFTILO, TIENILO, INDOLILO, BENZOISOTIAZOLILO O BENCISOXAZOLILO, CADA UNO OPCIONALMENTE SUSTITUIDO POR R 1 , TAL Y COMO SE DEFINIO ANTERIORMENTE: O R 5 Y R 6 , TOMADOS CONJUNTAMENTE CON LOS ATOMOS DE CARBONO A LOS QUE ESTAN UNIDOS, COMPLETAN UN ANILLO DE BENCENO, OPCIONALMENTE SUSTITUIDO POR R 1 ; O UNA SAL FARMACEUTICAMENTE ACEPTABLE DE LOS MISMOS. DICHOS COMPUESTOS SON UTILES PARA EL TRATAMIENTO DE LA ALTERACION DE LA DOPAMINA CEREBRAL.
ES97910866T 1996-10-15 1997-10-10 Derivados azaheterociclimetilo de 3,3,9 -tetrahidro-7h 1,4-dioxino (2,3-4) indol-8-0na. Expired - Lifetime ES2196312T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US73280796A 1996-10-15 1996-10-15

Publications (1)

Publication Number Publication Date
ES2196312T3 true ES2196312T3 (es) 2003-12-16

Family

ID=24945030

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97910866T Expired - Lifetime ES2196312T3 (es) 1996-10-15 1997-10-10 Derivados azaheterociclimetilo de 3,3,9 -tetrahidro-7h 1,4-dioxino (2,3-4) indol-8-0na.

Country Status (10)

Country Link
EP (1) EP0932609B1 (es)
JP (1) JP2001502327A (es)
AT (1) ATE240335T1 (es)
AU (1) AU4813897A (es)
CA (1) CA2268195C (es)
DE (1) DE69722020T2 (es)
DK (1) DK0932609T3 (es)
ES (1) ES2196312T3 (es)
PT (1) PT932609E (es)
WO (1) WO1998016530A1 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9627005D0 (en) * 1996-12-27 1997-02-12 Knoll Ag Therapeutic agents
US6927226B2 (en) 2001-04-26 2005-08-09 Wyeth Antidepressant azaheterocyclymethyl derivatives of 7,8-dihydro-3H-6,9-dioxa-1,3-diazacyclopenta[a]naphthalene
EP1381613B1 (en) 2001-04-26 2004-10-13 Wyeth Antidepressant azaheterocyclylmethyl derivatives of oxaheterocycle-fused-(1,4)-benzodioxans
US6861427B2 (en) * 2001-04-26 2005-03-01 Wyeth Azabicyclylmethyl derivatives of 2,3-dihydro-1,4-dioxino[2,3-f]quinoline as 5-HT1A antagonists
WO2002088129A1 (en) * 2001-04-26 2002-11-07 Wyeth Antidepressant azaheterocyclylmethyl derivatives of 2,3-dihydro-1,4-dioxino[2,3-f]quinazoline
US6800641B2 (en) * 2001-04-26 2004-10-05 Wyeth Antipsychotic aminomethyl derivatives of 7,8-dihydro-3H-6,9-dioxa-2,3-diaza-cyclopenta[a]naphthalene
CN1267434C (zh) 2001-04-26 2006-08-02 惠氏公司 抗抑郁的(SSSRI)7,8－二氢－3H－6,9－二氧杂－1,3－二氮杂环戊二烯并[a]萘的氮杂环基甲基衍生物
US6706736B2 (en) 2001-04-26 2004-03-16 Wyeth Antidepressant azaheterocyclylmethyl derivatives of oxaheterocycle-fused-[1,4]-benzodioxans
US6617334B2 (en) 2001-04-30 2003-09-09 Wyeth Antidepressant azaheterocyclylmethyl derivatives of 7,8-dihydro-1,6,9-trioxa-3-aza-cyclopenta[a]naphthalene
TR200402753T4 (tr) 2001-04-30 2004-11-22 Wyeth 7,8-Dihidro-1,6,9-trioksa-3-aza-siklopenta[a]naftalen'in antidepresan azaheterosiklmetil türevleri.
EP1408976B3 (en) 2001-07-20 2010-08-25 Psychogenics Inc. Treatment for attention-deficit hyperactivity disorder
US7153849B2 (en) * 2002-09-12 2006-12-26 Wyeth Antidepressant arylpiperazine derivatives of hetrocycle-fused benzodioxans
US6939877B2 (en) 2002-09-12 2005-09-06 Wyeth Antidepressant piperidine derivatives of heterocycle-fused benzodioxans

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2075057A1 (en) * 1990-03-15 1991-09-16 Pharmacia & Upjohn Company Llc Therapeutically useful heterocyclic indole compounds
DE4135474A1 (de) * 1991-10-28 1993-04-29 Bayer Ag 2-aminomethyl-chromane
DE4140540A1 (de) * 1991-12-09 1993-06-17 Bayer Ag Neue azaheterocyclylmethyl-chromane
IL119483A (en) * 1995-11-06 1999-06-20 American Home Prod 2-(Aminomethyl)-3,4,7,9- tetrahydro- 2H-pyrano-2[3,3-e]indol-8-ones their derivatives and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
DK0932609T3 (da) 2003-09-01
WO1998016530A1 (en) 1998-04-23
ATE240335T1 (de) 2003-05-15
CA2268195A1 (en) 1998-04-23
AU4813897A (en) 1998-05-11
JP2001502327A (ja) 2001-02-20
EP0932609B1 (en) 2003-05-14
EP0932609A1 (en) 1999-08-04
CA2268195C (en) 2006-08-29
PT932609E (pt) 2003-09-30
DE69722020D1 (de) 2003-06-18
DE69722020T2 (de) 2004-01-22

Similar Documents

Publication Publication Date Title
ES2196312T3 (es) Derivados azaheterociclimetilo de 3,3,9 -tetrahidro-7h 1,4-dioxino (2,3-4) indol-8-0na.
TW222584B (es)
IL99571A0 (en) Process for the preparation of water soluble camptothecin analogs,compounds prepared by said process,and methods of use thereof
WO1999067252A3 (en) Epothilone derivatives and their synthesis and use
HK1022639A1 (en) New use for 1,3-propanediol derivatives.
TW375615B (en) Galanthamine derivatives and their use as medicaments
MX9803455A (es) Derivados de indolalquilo de benzodioxanmetilamina como ligandos del receptor 5-ht1a.
DE3167774D1 (en) 4-substituted-2-oxoazetidine compounds, processes for their preparation, and their use for preparing antibiotics
NZ333798A (en) Arylcycloalkane carboxylic esters, their use for the treatment of urinary incontinence or irritable bowel syndrome, and method of manufacture.
NZ503710A (en) 2-Substituted- 4'-hydroxy-5,9,9-trimethyl-6,7-benzomorphan derivatives useful in treating vascular diseases
AU4200089A (en) Substituted beta-diketones
AU565745B2 (en) Imidazo(1,2-c)pyrimidines
PL337188A1 (en) Derivatives of 17beta - allyloxy (thio) alkyl - androstane for modulation of meiosis
TW334428B (en) Novel benzodiazepine derivatives
GR3021427T3 (en) Indole derivative
CA2144974A1 (en) Camphidine derivative, production thereof, and use thereof
TW353071B (en) Chromene compounds with neutroleptic activity, their preparation and pharmaceutical compositions